Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-01-01 @ 7:20 PM
Study NCT ID:
NCT05028504
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2021-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
Sponsor:
Sichuan Cancer Hospital and Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ALTERGO020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None